The latest update is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd has issued 10,810,811 ordinary shares without disclosure under the Corporations Act, as per their notice under Section 708A(5)(e). The company has confirmed compliance with relevant provisions of the Corporations Act and stated that there is no excluded information required to be disclosed. This issuance reflects the company’s ongoing operations and compliance, potentially impacting its financial positioning and stakeholder interests.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, trading as PILL, is a medical technology company based in Perth, Western Australia. The company is a leader in precision diagnostics and bio-analytical services, focusing on proteomics, which involves the large-scale study of protein structures and functions. Their mission is to enhance healthcare by developing innovative tools for better disease treatment.
YTD Price Performance: -51.25%
Average Trading Volume: 132,410
Technical Sentiment Signal: Buy
Current Market Cap: A$51.09M
For a thorough assessment of PIQ stock, go to TipRanks’ Stock Analysis page.